Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Geisinger becomes the first member of Risant Health

The award recognizes the efforts of groups engaged in appropriate laboratory test utilization

DANVILLE, Pa. – Geisinger Adult Gastroenterology and Laboratory Medicine were elected by The American Society for Clinical Pathology (ASCP) as one of their 2022 Choosing Wisely® Champions for advancing appropriate test utilization at the health system and demonstrating leadership of a local Choosing Wisely® effort.

ASCP’s Choosing Wisely® Champions program is part of ASCP’s broader Choosing Wisely® campaign, an initiative of the American Board of Internal Medicine (ABIM) Foundation, which seeks to advance a national dialogue on avoiding unnecessary medical tests, treatments, and procedures. The program recognizes the efforts of dedicated pathologists and laboratory professionals for making informed decisions about laboratory testing. Recommendations improve patient care and reduce healthcare costs, and the Choosing Wisely® Champions encourage their colleagues to use the right test at the right time for the right cost.

“This award recognizes the work that our Geisinger adult gastroenterology and laboratory medicine teams do each and every day to stand out as a leader in the field,” said Amanda Haynes, DO, FASCP, Division Chief of Clinical Pathology Professional Services, Quality, and Operations, Laboratory Medicine at Geisinger. “This honor would not have been achieved without the dedication of all our team members. We strive to be innovative and effective in everything that we do, making better health easier for our patients.”

Geisinger Adult Gastroenterology and Laboratory Medicine launched a successful Choosing Wisely® campaign across the Geisinger system to address inappropriate use of fecal occult blood testing (FOBT). Using education and electronic tools, provider decision-making was guided toward ordering FOBT for its intended use of colorectal cancer screening in ambulatory patients.

“Identifying Champions and sharing their successes allows all of us to learn from their efforts to improve healthcare delivery,” said Lee H. Hilborne, MD, MPH, DLM(ASCP)CM, FASCP, chair of the ASCP Effective Test Utilization Steering Committee. “The Geisinger team is an exemplar of Choosing Wisely® values and the application of this effective test utilization initiative.”

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country.  Learn more at or connect with us on Facebook, Instagram, LinkedIn and X.

Geisinger Logo

Media inquiries

Erika Hudock
Senior Communications Specialist
Content from General Links with modal content